Abstract
For the past three to four decades, the onset of acute respiratory distress syndrome (ARDS) has brought substantial insight into its epidemiology and pathophysiology. It is characterised by an acute lung injury resulting in widespread pulmonary oedema due to increased alveolar capillary permeability. Acute lung injury arises from the damaging effects of inflammatory mediators. Treatment of ARDS involves various modalities of supportive care categorised as ventilator and nonventilator measures. Berlin’s conference consensus definition of ARDS has been widely accepted in defining and categorising ARDS. The promising therapies for future include use of statins, aspirin, nebulised heparin, AdrenoMedulin, Interferon beta, Tumour necrosis factor (TNF alpha) receptor blockade, Angiotensin converting enzyme and keratinocytes growth factors.
Keywords: ARDS, berlins definition, prone ventilation, restrictive fluid strategy, steroids, ventilator.
Current Respiratory Medicine Reviews
Title:Acute Respiratory Distress Syndrome-Past, Present and Future
Volume: 11 Issue: 3
Author(s): S. Manimala Rao and Kartik Munta
Affiliation:
Keywords: ARDS, berlins definition, prone ventilation, restrictive fluid strategy, steroids, ventilator.
Abstract: For the past three to four decades, the onset of acute respiratory distress syndrome (ARDS) has brought substantial insight into its epidemiology and pathophysiology. It is characterised by an acute lung injury resulting in widespread pulmonary oedema due to increased alveolar capillary permeability. Acute lung injury arises from the damaging effects of inflammatory mediators. Treatment of ARDS involves various modalities of supportive care categorised as ventilator and nonventilator measures. Berlin’s conference consensus definition of ARDS has been widely accepted in defining and categorising ARDS. The promising therapies for future include use of statins, aspirin, nebulised heparin, AdrenoMedulin, Interferon beta, Tumour necrosis factor (TNF alpha) receptor blockade, Angiotensin converting enzyme and keratinocytes growth factors.
Export Options
About this article
Cite this article as:
Manimala Rao S. and Munta Kartik, Acute Respiratory Distress Syndrome-Past, Present and Future, Current Respiratory Medicine Reviews 2015; 11 (3) . https://dx.doi.org/10.2174/1573398X11666150716172854
DOI https://dx.doi.org/10.2174/1573398X11666150716172854 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Acute Myocarditis in Children: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Analogy of Cardiac and Renal Complications in Essential Hypertension and Aged SHR or L-NAME/SHR
Medicinal Chemistry Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Editorial (Thematic Issue: The Role of Creatine on Disease-Related Conditions)
Mini-Reviews in Medicinal Chemistry New Drugs for Epidural Analgesia
Current Drug Targets Animal Models to Study Plaque Vulnerability
Current Pharmaceutical Design Hyperhomocysteinemia and Sudden Cardiac Death: Potential Arrhythmogenic Mechanisms
Current Vascular Pharmacology Mid-Aortic Syndrome: A Rare Cause of Renovascular Hypertension in Childhood Treated Percutaneously with an Unusual Vascular Access
Current Pediatric Reviews Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal Chemistry Healthspan and Longevity in Mammals: A Family Game for Cellular Organelles?
Current Pharmaceutical Design Application of Cardiac Molecular Imaging Using Positron Emission Tomography in Evaluation of Drug and Therapeutics for Cardiovascular Disorders
Current Pharmaceutical Design Apoptotic Cell Clearance and Autoimmune Disorder
Current Medicinal Chemistry Possible Links of Age Related Hypertension and Evolution Imposed Features of Heart and Aorta
Current Aging Science Editorial [Hot Topic: Drug Metabolisms Associated with Human Microbiome (Guest Editor: Chun-Ming Huang) ]
Current Drug Metabolism Mechanisms and Medical Management of Exercise Intolerance in Hypertrophic Cardiomyopathy
Current Pharmaceutical Design Disparities in Cardiovascular Disease Risk in the United States
Current Cardiology Reviews Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update
Current Pharmaceutical Design Selective Glucocorticoid Receptor Ligands
Medicinal Chemistry Churg-Strauss Syndrome Presenting as Acute Necrotizing Eosinophilic Myocarditis: Concise Review of the Literature
Current Hypertension Reviews Appraisal of Saxagliptin as Treatment of Type 2 Diabetes
Current Drug Therapy